Walgreens, which invested more than $6B during the pandemic for a majority stake in primary care chain VillageMD, has now written off most of that bet as it races to close VillageMD outlets across the country.

The retailer revealed a $6B net loss in its quarterly results, most of which was attributed to what Walgreens CFO Manmohan Mahajan called "a mismatch" in the value of VillageMD in Walgreens' balance sheet and the actual market value of the primary care clinic subsidiary.

Mahajan told investors during an earnings call that his team had discovered the discrepancy and as a result Walgreens was forced to take a $5.8B goodwill impairment charge.

Want to continue reading?
Become a Free ALM Digital Reader.

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.